Ultrahuman Partners With Abu Dhabi Health Authority to Build Biological-Age Model for UAE
Ultrahuman and Abu Dhabi’s public-health authority will spend two years validating a biological-age model that combines clinical biomarkers with wearable data. UAE residents are eventually expected to access it via TAMM and Sahatna, without Ultrahuman receiving personally identifiable data.
Ultrahuman, a Bengaluru-based health tech startup known for its smart rings, announced in October 2026 that it has signed a two-year memorandum of understanding with the Abu Dhabi Public Health Center (ADPHC) to develop and validate a biological-age model intended for rollout across the United Arab Emirates.
The model will combine clinical biomarkers with data from wearable devices — including rings, wrist-worn devices, straps, and patches — to estimate how quickly an individual is aging and identify factors such as sleep, activity, cardiovascular health, and metabolism that may be accelerating or slowing that process. Ultrahuman and ADPHC will spend the next two years on research and clinical validation before a phased broader rollout, though no specific timeline for that rollout has been provided.
UAE residents will eventually be able to access their biological age through government digital-health platforms TAMM and Sahatna, according to the company. CEO Mohit Kumar told TechCrunch that the model was developed using Ultrahuman’s existing user data and will be deployed on UAE data without Ultrahuman having access to personally identifiable information. He also confirmed the model will not be trained on UAE data.
The partnership marks Ultrahuman’s first effort to deploy a health algorithm at a national scale. The UAE is already among the startup’s 10 largest markets, accounting for roughly 4% to 5% of overall revenue, and the company reports about 25% higher user retention there compared to other markets. Ultrahuman has sold approximately 800,000 smart rings globally.
The Abu Dhabi collaboration is not exclusive to Ultrahuman. Smart-ring rival Oura announced a separate partnership with the Department of Health – Abu Dhabi in May, focusing on women’s health and cardiometabolic risk. Kumar said Ultrahuman is not aware of another company working with Abu Dhabi specifically on a biological-age model.
The deal could expand Ultrahuman’s algorithmic reach well beyond its current customer base, which skews toward users aged 25 to 43, by exposing the model to a broader range of age groups through the UAE’s national health system.